Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone. Another busy day is on the way. This is to be expected, though, yes? After all, not much gets accomplished when one is sitting still. Just the same, we are able to enjoy a warm sun hovering over the Pharmalot corporate campus, where the mascots are lounging, the short people are hustling off, as usual, to their houses of learning and another cup of stimulation is brewing in the cafeteria. And this is our signal to get cracking. Meanwhile, here are some items of interest. Hope you have a grand day and keep us in mind if you run across anything interesting... Biosimilars Are Slow To Take Off In Europe (Reuters) Meningitis Vaccine Form Does Not Require Students To Waive Rights (The Princetonian) Novo Nordisk CEO Remains Confident About Pipeline (Reuters) FDA Extends Review On Biogen Hemophilia Drug (Pharma Times) India Dissolves Panel On Patented Drug Pricing (The Business Standard) Australians Pay 14 Times More For Drugs Than Other Countries (ABC) UK Drug Shortages Harm Patients In 75 Percent Of Cases (Pharma Times) EDITOR'S NOTE: Please check this post for...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs